Simplex Trading’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,300
Closed -$20K 10256
2023
Q2
$20K Sell
9,300
-28,000
-75% -$58.1K ﹤0.01% 6805
2023
Q1
$94K Sell
37,300
-3,100
-8% -$6.13K ﹤0.01% 5226
2022
Q4
$75K Buy
40,400
+21,700
+116% +$54.1K ﹤0.01% 5405
2022
Q3
$48K Sell
18,700
-31,700
-63% -$78.9K ﹤0.01% 6516
2022
Q2
$97K Buy
50,400
+41,800
+486% +$91.2K ﹤0.01% 5605
2022
Q1
$25K Sell
8,600
-2,200
-20% -$8.28K ﹤0.01% 8010
2021
Q4
$48K Buy
10,800
+3,300
+44% +$15.7K ﹤0.01% 7323
2021
Q3
$54K Hold
7,500
﹤0.01% 7438
2021
Q2
$51K Buy
7,500
+7,130
+1,927% +$57.6K ﹤0.01% 7629
2021
Q1
$261K Sell
370
-622
-63% -$4.48K ﹤0.01% 4321
2020
Q4
$620K Buy
992
+705
+246% +$4.15K ﹤0.01% 3154
2020
Q3
$155K Buy
287
+136
+90% +$673 ﹤0.01% 4423
2020
Q2
$78K Sell
151
-110
-42% -$489 ﹤0.01% 5071
2020
Q1
$82K Buy
261
+59
+29% +$218 ﹤0.01% 4586
2019
Q4
$81K Sell
202
-30
-13% -$104 ﹤0.01% 4725
2019
Q3
$100K Buy
232
+211
+1,005% +$844 ﹤0.01% 4322
2019
Q2
$8K Buy
21
+11
+110% +$52 ﹤0.01% 6257
2019
Q1
$5K Sell
10
-107
-91% -$691 ﹤0.01% 6499
2018
Q4
$60K Buy
117
+115
+5,750% +$873 ﹤0.01% 4365
2018
Q3
$1K Sell
2
-481
-100% -$4.85K ﹤0.01% 7245
2018
Q2
$492K Buy
483
+240
+99% +$2.72K ﹤0.01% 2476
2018
Q1
$15K Buy
243
+184
+312% +$2.74K ﹤0.01% 3657
2017
Q4
$3K Sell
59
-30
-34% -$626 ﹤0.01% 5023
2017
Q3
$20K Buy
89
+22
+33% +$512 ﹤0.01% 3179
2017
Q2
$12K Sell
67
-227
-77% -$5.02K ﹤0.01% 3843
2017
Q1
$125K Buy
294
+243
+476% +$3.83K 0.01% 1556
2016
Q4
$24K Sell
51
-19
-27% -$247 ﹤0.01% 2874
2016
Q3
$6K Buy
70
+50
+250% +$663 ﹤0.01% 4169
2016
Q2
$3K Buy
+20
New +$294 ﹤0.01% 4742

Simplex Trading's PRTK Position: Q3 2023 in Review

Simplex Trading sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 22 shares — an estimated $48 sold.

Simplex Trading first reported a position in PRTK in Q4 2014 and held it in 19 quarters. The position peaked at $911K in Q3 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

  • Simplex Trading reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 22 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $48.
  • Simplex Trading first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2014 and held it in 19 quarters.
  • Simplex Trading's Paratek Pharmaceuticals, Inc. position peaked at $911K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.